Momenta Pharmaceuticals, Inc. announced the promotion of Dr. Ganesh Kaundinya to Chief Operating Officer. Dr. Kaundinya, who assumed his new position effective September 25, 2017, will also continue to serve as Chief Scientific Officer and report directly to Craig Wheeler, company's President and Chief Executive Officer. In addition to his role as Chief Scientific Officer, Dr. Kaundinya will oversee the operational management of research and development, manufacturing, commercial activities, and program and alliance management.